Previous Close | 68.26 |
Open | 68.18 |
Bid | 67.72 x 100 |
Ask | 67.78 x 100 |
Day's Range | 67.68 - 68.35 |
52 Week Range | 60.47 - 76.56 |
Volume | |
Avg. Volume | 6,335,006 |
Market Cap | 210.053B |
Beta (5Y Monthly) | 0.17 |
PE Ratio (TTM) | 35.66 |
EPS (TTM) | 1.90 |
Earnings Date | N/A |
Forward Dividend & Yield | 1.45 (2.12%) |
Ex-Dividend Date | Feb 22, 2024 |
1y Target Est | 81.83 |
While AbbVie (ABBV) is set to buy Landos Biopharma, Novo Nordisk (NVO) is set to acquire Cardior Pharmaceuticals. FDA approves J&J's (JNJ) and Merck's (MRK) PAH drugs.
Data from an early-stage study shows that patients who received Viking's (VKTX) orally-administered obesity drug lost up to 5.3% of their body weight after 28 days.
In the most recent trading session, Astrazeneca (AZN) closed at $66.33, indicating a +0.71% shift from the previous trading day.